Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)

ILA 39.6

(0.25%)

Gross Profit Summary of Tikun Olam-Cannbit Pharmaceuticals Ltd

Tikun Olam-Cannbit Pharmaceuticals Ltd's latest annual gross profit in 2023 was -1.75 Million ILS , up 50.27% from previous year.
Tikun Olam-Cannbit Pharmaceuticals Ltd's latest quarterly gross profit in 2024 Q2 was 643 Thousand ILS , down 0.0% from previous quarter.
Tikun Olam-Cannbit Pharmaceuticals Ltd reported a annual gross profit of -3.53 Million ILS in annual gross profit 2022, up 72.95% from previous year.
Tikun Olam-Cannbit Pharmaceuticals Ltd reported a annual gross profit of -13.06 Million ILS in annual gross profit 2021, down -1734.27% from previous year.
Tikun Olam-Cannbit Pharmaceuticals Ltd reported a quarterly gross profit of 643 Thousand ILS for 2024 Q2, down 0.0% from previous quarter.
Tikun Olam-Cannbit Pharmaceuticals Ltd reported a quarterly gross profit of 1.19 Million ILS for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Tikun Olam-Cannbit Pharmaceuticals Ltd (2023 - 2011)

Historical Annual Gross Profit of Tikun Olam-Cannbit Pharmaceuticals Ltd (2023 - 2011)

Year	Gross Profit	Gross Profit Growth
2023	-1.75 Million ILS	50.27%
2022	-3.53 Million ILS	72.95%
2021	-13.06 Million ILS	-1734.27%
2020	-712 Thousand ILS	33.52%
2019	-1.07 Million ILS	-195.86%
2018	-362 Thousand ILS	0.0%
2017	- ILS	100.0%
2016	-701 Thousand ILS	34.73%
2015	-1.07 Million ILS	-92.82%
2014	-557 Thousand ILS	-130.26%
2013	1.84 Million ILS	336.03%
2012	-780 Thousand ILS	58.62%
2011	-1.88 Million ILS	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	643 Thousand ILS	-46.12%
2024 Q2	643 Thousand ILS	0.0%
2023 Q4	1.19 Million ILS	0.0%
2023 FY	-1.75 Million ILS	50.27%
2023 Q2	4.57 Million ILA	0.0%
2023 Q3	1.19 Million ILS	-73.88%
2023 Q1	4.57 Million ILS	0.64%
2022 Q2	4.51 Million ILA	0.0%
2022 Q4	4.54 Million ILA	0.0%
2022 FY	-3.53 Million ILS	72.95%
2022 Q1	4.51 Million ILS	370.42%
2022 Q3	4.54 Million ILS	0.64%
2021 Q2	5.49 Million ILS	0.0%
2021 Q1	5.49 Million ILS	79.15%
2021 FY	-13.06 Million ILS	-1734.27%
2021 Q3	-1.66 Million ILS	-130.37%
2021 Q4	-1.66 Million ILS	0.0%
2020 Q4	3.06 Million ILS	0.0%
2020 FY	-712 Thousand ILS	33.52%
2020 Q2	4.07 Million ILS	0.0%
2020 Q3	3.06 Million ILS	-24.76%
2020 Q1	4.07 Million ILS	0.0%
2019 Q1	- ILS	0.0%
2019 Q2	- ILS	0.0%
2019 FY	-1.07 Million ILS	-195.86%
2019 Q3	- ILS	0.0%
2019 Q4	- ILS	0.0%
2018 Q2	- ILS	0.0%
2018 Q4	- ILS	0.0%
2018 Q3	- ILS	0.0%
2018 Q1	- ILS	0.0%
2018 FY	-362 Thousand ILS	0.0%
2017 FY	- ILS	100.0%
2016 Q4	- ILS	0.0%
2016 Q3	- ILS	0.0%
2016 FY	-701 Thousand ILS	34.73%
2016 Q2	- ILS	0.0%
2016 Q1	- ILS	0.0%
2015 Q1	- ILS	0.0%
2015 Q4	- ILS	0.0%
2015 Q3	- ILS	0.0%
2015 Q2	- ILS	0.0%
2015 FY	-1.07 Million ILS	-92.82%
2014 Q1	- ILS	0.0%
2014 Q2	- ILS	0.0%
2014 FY	-557 Thousand ILS	-130.26%
2014 Q3	- ILS	0.0%
2014 Q4	- ILS	0.0%
2013 Q2	287 Thousand ILS	-89.0%
2013 FY	1.84 Million ILS	336.03%
2013 Q4	- ILS	0.0%
2013 Q1	2.6 Million ILS	0.0%
2013 Q3	- ILS	-100.0%
2012 FY	-780 Thousand ILS	58.62%
2011 FY	-1.88 Million ILS	0.0%

Peer Gross Profit Comparison of Tikun Olam-Cannbit Pharmaceuticals Ltd

Name	Gross Profit	Gross Profit Difference
Cannabotech LTD	-1.25 Million ILA	-39.777%